Fresenius SE KGaAXSWX:FRE 71 Return-on-Tangible-Equity is 63.65% as of Mar. 2026, which is 50% above its 10-year median of 42.38. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review. Among 583 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 84.56% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Fresenius SE KGaA's annualized net income for the quarter that ended in Mar. 2026 was CHF1,584 Mil. Fresenius SE KGaA's average shareholder tangible equity for the quarter that ended in Mar. 2026 was CHF2,488 Mil. Therefore, Fresenius SE KGaA's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 63.65%.
The historical rank and industry rank for Fresenius SE KGaA's Return-on-Tangible-Equity or its related term are showing as below:
XSWX:FRE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 27.59 Med: 42.38 Max: 67.6
Current: 67.6
During the past 13 years, Fresenius SE KGaA's highest Return-on-Tangible-Equity was 67.60%. The lowest was 27.59%. And the median was 42.38%.
XSWX:FRE's Return-on-Tangible-Equity is ranked better than 84.56% of 583
companies
in the Healthcare Providers & Services industry
Industry Median: 9.74
vs XSWX:FRE: 67.60
Fresenius SE KGaA (XSWX:FRE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Fresenius SE KGaA Return-on-Tangible-Equity Related Terms
Fresenius SE KGaA Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FRE vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 63.65% mean?
Fresenius SE KGaA (XSWX:FRE) has a Return-on-Tangible-Equity of 63.65% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fresenius SE KGaA and its competitors. This is 50% above median its historical median of 42.38. Over the past decade, Fresenius SE KGaA's Return-on-Tangible-Equity has ranged from 27.59 to 67.60. According to the industry distribution chart, Fresenius SE KGaA ranks #90 out of 583 companies in the Healthcare Providers & Services industry, placing it in the top 15.4%.
Is Fresenius SE KGaA's Return-on-Tangible-Equity too high?
Fresenius SE KGaA's current Return-on-Tangible-Equity of 63.65% is 50% above median its 10-year median of 42.38. Over the past 10 years, this metric has ranged from a low of 27.59 to a high of 67.60. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 9.74. Fresenius SE KGaA's value of 63.65% is 553.5% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #90 out of 583 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #90 out of 583 companies for Return-on-Tangible-Equity. This places Fresenius SE KGaA in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 9.74. Fresenius SE KGaA's value of 63.65% is 553.5% above this benchmark. Historically, Fresenius SE KGaA's own Return-on-Tangible-Equity has ranged from 27.59 to 67.60 over the past decade. While the company's 10-year median is 42.38 vs. the industry median of 9.74, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.74, based on 583 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Return-on-Tangible-Equity of 63.65% is 553.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Return-on-Tangible-Equity is 63.65%, which is 50% above median its own 10-year median of 42.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current Return-on-Tangible-Equity is 63.65%, which is 50% above median its 10-year median of 42.38 and 553.5% above the Healthcare Providers & Services industry median of 9.74. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Return-on-Tangible-Equity is 63.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
Return-on-Tangible-Equity: 63.65% (50% above median its 10-year median of 42.38)
GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
Industry Position: 553.5% above the Healthcare Providers & Services median (#90 of 583)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
